Press Release – New York, NY – September 21, 2023 – Sichenzia Ross Ference LLP announced today that it represented Biotricity, Inc. (NASDAQ: “BTCY”) (the “Company”), a medical diagnostic and consumer …
Sichenzia Ross Ference LLP Represents Biotricity, Inc. in $50 Million At-The-Market Offering Facility
Press Release – New York, NY – March 23, 2022 – Sichenzia Ross Ference LLP announced today that it represented Biotricity, Inc. (NASDAQ: “BTCY”), a medical diagnostic and consumer healthcare …
Sichenzia Ross Ference LLP Represents Biotricity in $15.15 Million Underwritten Public Offering and NASDAQ Uplisting
Press Release – New York, NY – August 31, 2021 – Sichenzia Ross Ference LLP today announced that it represented Biotricity, Inc. (NASDAQ: BTCY), a medical diagnostic and consumer healthcare technology …
Sichenzia Ross Ference LLP Represents Biotricity Inc. in a $6 Million Private Placement of its Series A Convertible Preferred Stock
Press Release – New York, New York - December 19, 2019 - Sichenzia Ross Ference LLP announced today that it represented Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare …